Dr Meenu Singh develops mHealth-based spirometry to monitor lung health in inaccessible areas

Saturday, March 19, 2016

by Pooja Pandey

Chandigarh: Dr Meenu Singh, professor of paediatrics at the Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh has developed mHealth (mobile-health) technology based spirometry that monitors the lung health using telemedicine technology in inaccessible areas.

Dr Meenu Singh

Dr Meenu Singh

“Basically it is a telemonitoring device which can be taken to the community health centres and monitor the diseases. It is a spirometry which works with a GPRS enabled mobile SIM card through which reports are sent to the database which can be accessed on smartphones or on computers to get the details,” Dr Singh told India Medical Times.

Explaining the workings of the device, Dr Singh said, “If a patient is at a remote place then the telemonitoring van with a trained person who knows how to use the mHealth technology can get to the patient to collect information and that information can be accessed by a doctor on her smartphone. She gets an alert on her smartphone every time some information about the patient is provided or updated.”

“This mHealth technology can be used in asthma, COPD (chronic obstructive pulmonary disease) which is very common in Delhi and in other respiratory diseases,” added Dr Singh, who is also head of Paediatric Pulmonology, Asthma and Allergy Clinics, at the Advanced Paediatric Centre, PGIMER.

According to Dr Singh, her innovation has been successfully tested in the union territory of Chandigarh and in some parts of Himachal Pradesh.

by Pooja Pandey

Categories: NEWS, Telemedicine

Tags: , , , , ,

  More from NEWS

Indian pharmaceutical market to reach $56 billion in 2020


India’s ‘first women hospital’ inaugurated in Delhi


Ability to provide sight being shifted from corneal surgeries to newer technologies


Govt may reduce seats in surgical super-speciality courses that fail to attract doctors


New AI able to identify & predict development of cancer symptom clusters


Humira approved in Japan for treatment of Hidradenitis Suppurativa

Comments »

No comments yet.

Name (required)
E-mail (required - never shown publicly)
URI
Your Comment (smaller size | larger size)
You may use <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong> in your comment.